SGLT2 inhibitors reduce the risk of hospitalization for heart failure and amputation rate compared with incretin-based therapy in patients with diabetic foot disease: A nationwide population-based study

Published: 13 November 2023| Version 1 | DOI: 10.17632/jdv9bjtnxw.1
Contributor:
Yi-Hsuan Lin

Description

supplementary table and figures

Files

Steps to reproduce

from NHIRD

Categories

Diabetes, Heart Failure, Amputation

Licence